ResearcherUniversità Cattolica del Sacro CuoreActive in the last 2 years

Enrico Celestino Nista

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-3668-8906; OpenAlex author ID A5028786021. Sources: OpenAlex.

Their work

Papers: 5 (first author 1, last author 1)
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 9

Papers, trials and grants by year

2023: 3 papers · 2024: 1 paper · 2025: 1 paper

Papers 5

Microbiota and Pancreatic Cancer: New Therapeutic Frontiers Between Engineered Microbes, Metabolites and Non-Bacterial Components. First author DOI 10.3390/cancers17223618 ↗
The Past, Present, and Future of Biomarkers for the Early Diagnosis of Pancreatic Cancer. Co-author DOI 10.3390/biomedicines12122840 ↗
Pancreatic Cancer Resistance to Treatment: The Role of Microbiota. Co-author DOI 10.3390/biomedicines11010157 ↗
State-of-the-Art and Upcoming Innovations in Pancreatic Cancer Care: A Step Forward to Precision Medicine. Last author DOI 10.3390/cancers15133423 ↗
Diagnostic and Prognostic Role of Extracellular Vesicles in Pancreatic Cancer: Current Evidence and Future Perspectives. Co-author DOI 10.3390/ijms24010885 ↗

Closest collaborators

The 9 strongest of 9 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Marcello Candelli · 3 shared papers, 2023–2025 · strength 0.61
Sara Sofia De Lucia · 2 shared papers, 2023–2025 · strength 0.43
- Paper Microbiota and Pancreatic Cancer: New Therapeutic Frontiers Between Engineered Microbes, Metabolites and Non-Bacterial … DOI 10.3390/cancers17223618 ↗
- Paper State-of-the-Art and Upcoming Innovations in Pancreatic Cancer Care: A Step Forward to Precision Medicine. DOI 10.3390/cancers15133423 ↗
Federica Vitale · 2 shared papers, 2023–2024 · strength 0.37
- Paper The Past, Present, and Future of Biomarkers for the Early Diagnosis of Pancreatic Cancer. DOI 10.3390/biomedicines12122840 ↗
- Paper Diagnostic and Prognostic Role of Extracellular Vesicles in Pancreatic Cancer: Current Evidence and Future Perspectives. DOI 10.3390/ijms24010885 ↗
Lorenzo Zileri Dal Verme · 2 shared papers, 2023–2024 · strength 0.37
- Paper The Past, Present, and Future of Biomarkers for the Early Diagnosis of Pancreatic Cancer. DOI 10.3390/biomedicines12122840 ↗
- Paper Diagnostic and Prognostic Role of Extracellular Vesicles in Pancreatic Cancer: Current Evidence and Future Perspectives. DOI 10.3390/ijms24010885 ↗
Alberto Nicoletti · 2 shared papers, 2023–2024 · strength 0.37
- Paper The Past, Present, and Future of Biomarkers for the Early Diagnosis of Pancreatic Cancer. DOI 10.3390/biomedicines12122840 ↗
- Paper Diagnostic and Prognostic Role of Extracellular Vesicles in Pancreatic Cancer: Current Evidence and Future Perspectives. DOI 10.3390/ijms24010885 ↗
Giulia Pignataro · 1 shared paper, 2025 · strength 0.26
- Paper Microbiota and Pancreatic Cancer: New Therapeutic Frontiers Between Engineered Microbes, Metabolites and Non-Bacterial … DOI 10.3390/cancers17223618 ↗
Teresa Mezza · 1 shared paper, 2023 · strength 0.18
- Paper Pancreatic Cancer Resistance to Treatment: The Role of Microbiota. DOI 10.3390/biomedicines11010157 ↗
Sergio Alfieri · 1 shared paper, 2024 · strength 0.18
- Paper The Past, Present, and Future of Biomarkers for the Early Diagnosis of Pancreatic Cancer. DOI 10.3390/biomedicines12122840 ↗
Tommaso Schepis · 1 shared paper, 2023 · strength 0.17
- Paper State-of-the-Art and Upcoming Innovations in Pancreatic Cancer Care: A Step Forward to Precision Medicine. DOI 10.3390/cancers15133423 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.